Neurocrine Biosciences Inc Revenue per Employee (NBIX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neurocrine Biosciences Inc   (NASDAQ: NBIX)
 

Neurocrine Biosciences Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 41.24% in the third quarter 2026, year on year to cumulative value of $3,702 million, Neurocrine Biosciences Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,850,850, this is below the company average.
Within the Healthcare sector Employees of 49 other companies have achieved higher revenue per employee. While Neurocrine Biosciences Inc 's total ranking has deteriorated compared to the previous quarter from 233 to 556. Neurocrine Biosciences Inc has 2,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NBIX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 41.24 % 39.49 % 42.25 % 28.33 % 27.78 %
Sales per Employee (TTM) $ 1,850,850 1,686,950 1,551,200 1,430,250 1,341,350
NBIX's Total Ranking # 556 # 233 # 109 # 59 #
Seq. Revenue Change 17.07 % 17.74 % 1.12 % 1.33 % 15.62 %

NBIX Company Profile >> Back to NBIX Efficiency Comparisons >> Compare NBIX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 50
Overall Market # 556

Revenue per Employee Statistics
High Average Low
$ 1,551,200 $ 659,211 $ 12,068
(Mar 31 2026)   (Dec 31 2013)



Financial Statements
Neurocrine Biosciences Inc 's Revenue MRQ $ 1,123 Millions Visit NBIX's Income Statement
Neurocrine Biosciences Inc 's Revenues TTM $ 3,702 Millions Visit NBIX's aggregate revenue growth
What are NBIX's Sales? Visit NBIX's Sales by Segment




Other Ratios
Neurocrine Biosciences Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NBIX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NBIX's Competitors
Revenue per Employee for NBIX's Suppliers
Revenue per Employee for NBIX's Customers

You may also want to know
NBIX's Sales Growth Rates NBIX's Pe Price to earnings ratio NBIX's Receivables Turnover Ratio NBIX's Stock Quote
NBIX's Net Income Growth Rates NBIX's Ps Price to Sales ratio NBIX's Sales per Employee NBIX's Asset Turnover Ratio
NBIX's Net Margin NBIX's Pb Price to Book ratio NBIX's Financial Strength Ratios NBIX's Dividend Payout Ratio
Date modified: 2026-11-03T10:01:40+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.